Fondazione Golinelli
Home News FIRST EXIT FOR G-FACTOR: SANTEX INVESTS ON RELIEF
Del 30-04-2021

FIRST EXIT FOR G-FACTOR: SANTEX INVESTS ON RELIEF

Santex spa a leading Italian company in the production of high quality medical devices, enters the nominal capital of Relief srl, a spin-off of the Institute of BioRobotics of the Sant'Anna School of Advanced Studies which deals with the development of innovative devices for urinary incontinence. The agreement consists in a capital increase that will favor the industrial development of the product and the consequent entry on the market. An important result, which testifies to the increasingly evident centrality of third mission activities in Italian universities. The agreement with Santex – highlights a note – give way to the productive and technological transformation of a "knowledge" born within the research laboratories of the Scuola Sant'Anna and developed also thanks to the entrepreneurial courage of G-Factor of the Fondazione Golinelli, first investor who favored the establishment of Relief as an innovative spin-off company.

 

Relief is a leader in the design of an artificial urinary sphincter that, unlike common solutions, is implemented in a minimally invasive regime and is able to restore urinary continence, significantly improving the patient's quality of life. Thanks to Relief, Santex will present a complementary solution to the products it already markets, thus expanding its offer in the market of medical devices and, specifically, urinary incontinence.

 

"Today, exactly 24 months after the establishment of Relief as an innovative startup, G-Factor has sold its entire minority shareholding to an important industrial partner, which will contribute to its technological and entrepreneurial development, favoring its entry into the world-class market to international level - declares Antonio Danieli, G-Factor’s sole director and Vice-president of the Golinelli

Foundation - We believed and invested in Relief right from the start, not only with financial resources: we have always lived our role as shareholder as that of a partner that accompanies the team towards a first big milestone. Now, we have completed our task within the startup and we can wish the whole Relief srl team a bright future of important successes ".

 

 

Learn more about the news on the page of the press agency Askanews: https://www.askanews.it/cronaca/2021/04/29/incontinenza-urinaria-dispositivo-di-relief-si-avvicina-a-mercato-pn_20210429_00088/